SCHEMBL22632226

SCHEMBL22632226

CC(=O)NCCc1cc(=O)oc2cc(N)ccc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1B P49286 4/20 0.60
▸ MTNR1A P48039 4/20 0.60
▸ SLC18A1 P54219 1/20 0.51
▸ SLC18A2 Q05940 1/20 0.51
▸ ALDH1A1 P00352 5/20 0.50
▸ GAA P10253 4/20 0.50
▸ KDM4E B2RXH2 4/20 0.50
▸ HPGD P15428 3/20 0.50
▸ GLA P06280 2/20 0.50
▸ CASP1 P29466 2/20 0.50
▸ CASP7 P55210 2/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ CA12 O43570 1/20 0.50
▸ CA1 P00915 1/20 0.50
▸ CA9 Q16790 1/20 0.50
▸ HSD17B3 P37058 3/20 0.48
▸ ERAP1 Q9NZ08 1/20 0.46
▸ KMT2A Q03164 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ ATM Q13315 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24623284 0.86 SLC18A1 (0.48) MTNR1BMTNR1ASLC18A1SLC18A2ALDH1A1
SCHEMBL22632227 0.84 SLC18A1 (0.59) SLC18A1SLC18A2ALDH1A1GAAKDM4E
SCHEMBL22632322 0.82 MTNR1A (0.82) MTNR1BMTNR1AALDH1A1GAAKDM4E
SCHEMBL22632228 0.82 MTNR1A (0.58) MTNR1BMTNR1ASLC18A1SLC18A2ALDH1A1
SCHEMBL24623257 0.81 SLC18A1 (0.52) MTNR1BMTNR1ASLC18A1SLC18A2ALDH1A1
SCHEMBL14827224 0.80 ALDH1A1 (0.56) SLC18A1SLC18A2ALDH1A1GAAKDM4E
SCHEMBL8594115 0.79 HSD17B3 (0.68) SLC18A1SLC18A2ALDH1A1GAAKDM4E
SCHEMBL22632306 0.78 MTNR1B (0.53) MTNR1BMTNR1ASLC18A1SLC18A2ALDH1A1
SCHEMBL22632307 0.78 MTNR1A (0.53) MTNR1BMTNR1ASLC18A1SLC18A2ALDH1A1
SCHEMBL5138290 0.77 HSD17B3 (0.66) SLC18A1SLC18A2ALDH1A1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020223174-A1 COUMARIN-MODIFIED ANDROGENS FOR THE TREATMENT OF PROSTATE CANCER HEALTH RESEARCH, INC. (US) 2020-11-05 — — WO disclosed
Send feedback